176 related articles for article (PubMed ID: 38190141)
1. Evaluating ApoL1 Genetic Testing Policy Options for Transplant Centers: A Delphi Consensus Panel Project with Stakeholders.
McIntosh T; Walsh H; Baldwin K; Iltis A; Mohan S; Sawinski D; Goodman M; DuBois JM
Clin J Am Soc Nephrol; 2024 Apr; 19(4):494-502. PubMed ID: 38190141
[TBL] [Abstract][Full Text] [Related]
2. Variation of
McIntosh T; Mohan S; Sawinski D; Iltis A; DuBois JM
Prog Transplant; 2020 Mar; 30(1):22-28. PubMed ID: 31838940
[TBL] [Abstract][Full Text] [Related]
3. Apolipoprotein L1 Opinions of African American Living Kidney Donors, Kidney Transplant Patients, and Nonpatients.
Harris DD; Fleishman A; Pavlakis M; Pollak MR; Baliga PK; Rohan V; Kayler LK; Rodrigue JR
J Surg Res; 2022 Sep; 277():116-124. PubMed ID: 35489216
[TBL] [Abstract][Full Text] [Related]
4. African American Living Donors' Attitudes About APOL1 Genetic Testing: A Mixed Methods Study.
Gordon EJ; Amόrtegui D; Blancas I; Wicklund C; Friedewald J; Sharp RR
Am J Kidney Dis; 2018 Dec; 72(6):819-833. PubMed ID: 30360961
[TBL] [Abstract][Full Text] [Related]
5. A National Survey of Transplant Surgeons and Nephrologists on Implementing
Gordon EJ; Wicklund C; Lee J; Sharp RR; Friedewald J
Prog Transplant; 2019 Mar; 29(1):26-35. PubMed ID: 30541404
[TBL] [Abstract][Full Text] [Related]
6. Apolipoprotein L1 Testing in African Americans: Involving the Community in Policy Discussions.
Young BA; Blacksher E; Cavanaugh KL; Freedman BI; Fullerton SM; Kopp JB; Umeukeje EM; West KM; Wilson JG; Burke W;
Am J Nephrol; 2019; 50(4):303-311. PubMed ID: 31480040
[TBL] [Abstract][Full Text] [Related]
7. APOL1 Genetic Testing in Living Kidney Transplant Donors.
Mohan S; Iltis AS; Sawinski D; DuBois JM
Am J Kidney Dis; 2019 Oct; 74(4):538-543. PubMed ID: 30982552
[TBL] [Abstract][Full Text] [Related]
8. A Focus Group Study on African American Living Donors' Treatment Preferences, Sociocultural Factors, and Health Beliefs About Apolipoprotein L1 Genetic Testing.
Gordon EJ; Amórtegui D; Blancas I; Wicklund C; Friedewald J; Sharp RR
Prog Transplant; 2019 Sep; 29(3):239-247. PubMed ID: 31146624
[TBL] [Abstract][Full Text] [Related]
9. Practical Considerations for APOL1 Genotyping in the Living Kidney Donor Evaluation.
Mena-Gutierrez AM; Reeves-Daniel AM; Jay CL; Freedman BI
Transplantation; 2020 Jan; 104(1):27-32. PubMed ID: 31449181
[TBL] [Abstract][Full Text] [Related]
10. Introducing Genetic Tests With Uncertain Implications in Living Donor Kidney Transplantation: ApoL1 as a Case Study.
Ross LF; Thistlethwaite JR
Prog Transplant; 2016 Sep; 26(3):203-6. PubMed ID: 27302054
[TBL] [Abstract][Full Text] [Related]
11. Implementation of a culturally competent
Smith JD; Agrawal A; Wicklund C; Duquette D; Friedewald J; Rasmussen LV; Gacki-Smith J; Tandon SD; Muhammad LN; Yancy CW; Dong S; Cooper M; Gilbert A; Shetty A; Gordon EJ
BMJ Open; 2023 May; 13(5):e067657. PubMed ID: 37188469
[TBL] [Abstract][Full Text] [Related]
12. Cases in Precision Medicine: APOL1 and Genetic Testing in the Evaluation of Chronic Kidney Disease and Potential Transplant.
Neugut YD; Mohan S; Gharavi AG; Kiryluk K
Ann Intern Med; 2019 Nov; 171(9):659-664. PubMed ID: 31590185
[TBL] [Abstract][Full Text] [Related]
13. Impact of education on APOL1 testing attitudes among prospective living kidney donors.
Nestor JG; Li AJ; King KL; Husain SA; McIntosh TJ; Sawinski D; Iltis AS; Goodman MS; Walsh HA; DuBois JM; Mohan S
Clin Transplant; 2022 Jan; 36(1):e14516. PubMed ID: 34661305
[TBL] [Abstract][Full Text] [Related]
14. Apolipoprotein L1 gene variants in deceased organ donors are associated with renal allograft failure.
Freedman BI; Julian BA; Pastan SO; Israni AK; Schladt D; Gautreaux MD; Hauptfeld V; Bray RA; Gebel HM; Kirk AD; Gaston RS; Rogers J; Farney AC; Orlando G; Stratta RJ; Mohan S; Ma L; Langefeld CD; Hicks PJ; Palmer ND; Adams PL; Palanisamy A; Reeves-Daniel AM; Divers J
Am J Transplant; 2015 Jun; 15(6):1615-22. PubMed ID: 25809272
[TBL] [Abstract][Full Text] [Related]
15. Opinions of African American adults about the use of apolipoprotein L1 (ApoL1) genetic testing in living kidney donation and transplantation.
Berrigan M; Austrie J; Fleishman A; Tercyak KP; Pollak MR; Pavlakis M; Rohan V; Baliga PK; Kayler LK; Feeley TH; Rodrigue JR
Am J Transplant; 2021 Mar; 21(3):1197-1205. PubMed ID: 32659871
[TBL] [Abstract][Full Text] [Related]
16. Apolipoprotein L1 Gene Effects on Kidney Transplantation.
Freedman BI; Locke JE; Reeves-Daniel AM; Julian BA
Semin Nephrol; 2017 Nov; 37(6):530-537. PubMed ID: 29110760
[TBL] [Abstract][Full Text] [Related]
17. Apolipoprotein L1: role in the evaluation of kidney transplant donors.
Lentine KL; Mannon RB
Curr Opin Nephrol Hypertens; 2020 Nov; 29(6):645-655. PubMed ID: 33009133
[TBL] [Abstract][Full Text] [Related]
18. Testing for High-Risk APOL1 Alleles in Potential Living Kidney Donors.
Riella LV; Sheridan AM
Am J Kidney Dis; 2015 Sep; 66(3):396-401. PubMed ID: 26049628
[TBL] [Abstract][Full Text] [Related]
19. Clinical Genetic Testing for APOL1: Are we There Yet?
Young BA; Fullerton SM; Wilson JG; Cavanaugh K; Blacksher E; Spigner C; Himmelfarb J; Burke W
Semin Nephrol; 2017 Nov; 37(6):552-557. PubMed ID: 29110763
[TBL] [Abstract][Full Text] [Related]
20. APOL1 Genotype and Kidney Transplantation Outcomes From Deceased African American Donors.
Freedman BI; Pastan SO; Israni AK; Schladt D; Julian BA; Gautreaux MD; Hauptfeld V; Bray RA; Gebel HM; Kirk AD; Gaston RS; Rogers J; Farney AC; Orlando G; Stratta RJ; Mohan S; Ma L; Langefeld CD; Bowden DW; Hicks PJ; Palmer ND; Palanisamy A; Reeves-Daniel AM; Brown WM; Divers J
Transplantation; 2016 Jan; 100(1):194-202. PubMed ID: 26566060
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
